Metropolitan Health Networks
The 10-second takeaway
For the quarter ended March 31 (Q1), Metropolitan Health Networks beat slightly on revenues and missed estimates on earnings per share.
Compared with the prior-year quarter, revenue improved significantly and GAAP earnings per share dropped.
Margins dropped across the board.
Metropolitan Health Networks reported revenue of $195.2 million. The two analysts polled by S&P Capital IQ foresaw a top line of $192.1 million on the same basis. GAAP reported sales were much higher than the prior-year quarter's $94.7 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.18. The two earnings estimates compiled by S&P Capital IQ predicted $0.20 per share. GAAP EPS of $0.18 for Q1 were 5.3% lower than the prior-year quarter's $0.19 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 19.4%, 90 basis points worse than the prior-year quarter. Operating margin was 10.9%, 260 basis points worse than the prior-year quarter. Net margin was 4.1%, 430 basis points worse than the prior-year quarter.
Next quarter's average estimate for revenue is $195.7 million. On the bottom line, the average EPS estimate is $0.24.
Next year's average estimate for revenue is $771.8 million. The average EPS estimate is $0.91.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 223 members out of 235 rating the stock outperform, and 12 members rating it underperform. Among 32 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 28 give Metropolitan Health Networks a green thumbs-up, and four give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Metropolitan Health Networks is buy, with an average price target of $9.65.
The health-care investing landscape is littered with also-rans and a few major winners. Is Metropolitan Health Networks prepared for the future? Read "Discover the Next Rule-Breaking Multibagger" to learn about a company David Gardner believes will deliver amazing returns during the next few years. Get instant access to this free report.
- Add Metropolitan Health Networks to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings. He is the co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.